Acute hepatitis C increases in some age groups, decreases in others
New research announced Aug. 9 found that of those diagnosed with acute hepatitis C, only one in three with health insurance receive treatment, according to the Centers for Diseases Control and Prevention (CDC). Without treatment, liver disease, liver cancer, and death can occur. In 2019, hepatitis C (commonly abbreviated “HCV” for hepatitis C virus) contributed to the deaths of 14,000 people in US CDC reports that acute hepatitis C diagnoses increased by 31% among people aged 40 to 49 and 23% in 2019. people aged 30 to 39. However, the rate of acute hepatitis C has fallen in the 20-29 age group for the first time in a decade.